Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,080,121 | 0.89 | Buy | 0.89 | $36.75 | $76,444,447 | SEC |
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2024 Q2 | 7,849 | 0.02 | Add 272.87% | 0.01 | $142.74 | $1,120,366 | SEC |
| 2024 Q1 | 2,105 | 0.01 | Buy | 0.01 | $128.40 | $270,282 | SEC |
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q1 | 2,156 | 0.01 | Reduce 6.42% | <0.01 | $159.14 | $343,106 | SEC |
| 2022 Q4 | 2,304 | 0.01 | Reduce 6.91% | <0.01 | $135.34 | $311,823 | SEC |
| 2022 Q3 | 2,475 | 0.01 | Buy | 0.01 | $99.80 | $247,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2020 Q4 | 2,658 | <0.01 | Reduce 70.25% | <0.01 | $69.98 | $186,000 | SEC |
| 2020 Q3 | 8,933 | 0.01 | Buy | 0.01 | $69.41 | $620,000 | SEC |